Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-15

Clinical Trial Update: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes

View source ↗

Summary

A completed clinical trial evaluated microRNAs as biomarkers for aortic aneurysm in hereditary aortopathy syndromes such as Marfan syndrome and Loeys-Dietz synd…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: Marfan Syndrome, Loeys-Dietz Syndrome | Status: COMPLETED